admin Share This! FacebookTwitterPinterestLinkedIn Investing News Novo Nordisk Boosts Guidance as Sales of Weight-Loss Drug Wegovy Soar August 10, 202389 Views1 Min Read Novo Nordisk raised its outlook as revenue from its popular weight-loss treatment, Wegovy, skyrocketed. You may also like Investing News Why Stocks Generally Outperform Bonds 3 hours ago Investing News How Yahoo Makes Money 6 hours ago Investing News How to Calculate Goodwill 6 hours ago Markets Advanced at Midday as Consumer Inflation Rose Less Than Expected Attending College in Europe or Abroad Share This! FacebookTwitterPinterestLinkedIn Newsletter NavigationInvesting News Market Insider Stock Market Stocks to buy Stocks to sell Dividend Stocks Trader Talk Videos Privacy Policy DMCA / Copyrights Disclaimer Terms and Conditions Disclaimer Whitelist Us